Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE ...

Shares of Sonnet BioTherapeutics, Inc. (SONN) soared on Monday after the company entered a definitive business combination agreement with Rorschach I LLC to build a reserve of HYPE, the token of the ...

Sonnet BioTherapeutics to merge with Rorschach I LLC in a $888 million deal, forming crypto-focused Hyperliquid Strategies ...

HYPE rallies toward $50 after Sonnet BioTherapeutics combines with Rorschach to launch a $583 million Hyperliquid token ...

You’d think that in a sleepy town like Camarillo, where the hottest debates—usually in the local Facebook mom group—revolve ...

Rorschach tests play with the human imagination and our mind's ability to impart meaning onto the world around us – but what does AI see in them?

Sonnet BioTherapeutics is merging with Rorschach I LLC to form Hyperliquid Strategies in an $888M deal. The merger boosts HYPE token’s market momentum.

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Experts put AI to the test, the Rorschach test, that is, and the results are pretty much exactly what you'd expect.

The Rorschach test is a psychological test designed by psychiatrist Hermann Rorschach in the early 1900s. The test involves presenting a subject with images of inkblots; the person then describes ...